MRKR
Marker Therapeutics, Inc.
There isn't enough reported data to score MRKR yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
MRKR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Unavailable | |
| Unavailable |
MRKR's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MRKR PE Valuation
MRKR has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MRKR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| -- | |
| Limited | |
| Low |
Analysts expect MRKR's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MRKR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.47 | +$0.89 |
| Q1 2026 | -$0.67 | +$0.65 |
| Q4 2025 | -$0.91 | +$0.28 |
| Q3 2025 | -$1.22 | -$0.12 |
| Q2 2025 | -$1.36 | -$0.18 |
| Q1 2025 | -$1.32 | -$0.68 |
| Q4 2024 | -$1.19 | -$0.25 |
| Q3 2024 | -$1.10 | $0.00 |
MRKR is still losing money, but far less than before: $0.47 per share over the past year, against $70.80 at its worst in late 2019.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over MRKR on earnings quality, reporting a profit while its opponent remains loss making.
MRKR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $751.7K | +115% |
| Q4 2025 | $1.1M | -51% |
| Q3 2025 | $1.2M | -36% |
| Q2 2025 | $861.2K | -26% |
| Q1 2025 | $349.1K | -72% |
| Q4 2024 | $2.3M | +113% |
| Q3 2024 | $1.9M | +648% |
| Q2 2024 | $1.2M | +53% |
MRKR has the stronger quarterly revenue trend. Revenue is up 115% for MRKR versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -542% | +778 points |
| Q4 2025 | -171% | +0.7 points |
| Q3 2025 | -173% | -49 points |
| Q2 2025 | -495% | -297 points |
| Q1 2025 | -1320% | -1115 points |
| Q4 2024 | -171% | +107 points |
| Q3 2024 | -125% | +1118 points |
| Q2 2024 | -197% | +345 points |
MRKR's operating margin was −542% last quarter, up 778 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
MRKR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.7M | -$1.8M |
| Q1 2026 | -$1.4M | +$4.1M |
| Q4 2025 | -$1.9M | +$2.8M |
| Q3 2025 | -$2.7M | -328% |
| Q2 2025 | -$1.9M | +$1.7M |
| Q1 2025 | -$5.5M | -$1.7M |
| Q4 2024 | -$4.7M | -$2.3M |
| Q3 2024 | $1.2M | +$2.3M |
MRKR has burned cash in almost every quarter: −$10M over the past year, against −$11M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over MRKR on cash generation, producing positive trailing cash flow while its opponent burns cash.
MRKR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +38% | +5.4M shares |
| 3 years | +120% | +10.5M shares |
| 5 years | +133% | +11M shares |
| Available history | +323% | +14.7M shares |
MRKR has 19M diluted shares, up 38% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over MRKR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
MRKR Net Leverage
MRKR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
MRKR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.7 | Neutral |
| Stochastic | 7.4 | Oversold |
MRKR's weekly RSI is 37 (neutral) and its Stochastic is 7 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MRKR PE vs Healthcare Sector
MRKR has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
MRKR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.99 | 9.1% below |
| 20 week MA | $1.16 | 22% below |
| 50 week MA | $1.36 | 34% below |
| 100 week MA | $1.42 | 37% below |
| 200 week MA | $2.53 | 64% below |
MRKR is in a downtrend: it's below all five of its weekly moving averages, and 64% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over MRKR on trend strength, trading above more of its moving averages.
MRKR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.7 | $15.3 | -50% |
| 2021 | $15.3 | $9.98 | -35% |
| 2022 | $9.98 | $2.60 | -74% |
| 2023 | $2.60 | $5.50 | +112% |
| 2024 | $5.50 | $3.49 | -37% |
| 2025 | $3.49 | $1.44 | -59% |
| 2026 YTD | $1.44 | $0.90 | -38% |
MRKR's yearly returns have swung widely, from +112% in 2023 to −74% in 2022. It's down 38% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over MRKR on returns for 2026, with the stronger performance.